Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-06-01
2010-06-22
Carlson, Karen Cochrane (Department: 1652)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S328000, C435S194000
Reexamination Certificate
active
07741290
ABSTRACT:
Methods are described for slowing or inhibiting the progression of heart failure in a mammalian subject suffering from chronic hypertension. The methods involve administering an εPKC, β1PKC, or βIIPKC peptide inhibitor, examples of which are provided.
REFERENCES:
patent: 5783405 (1998-07-01), Mochly-Rosen et al.
patent: 6165977 (2000-12-01), Mochly-Rosen
patent: 6225301 (2001-05-01), Ways et al.
patent: 6933275 (2005-08-01), Mochly-Rosen et al.
patent: 2002/0168354 (2002-11-01), Mochly-Rosen
patent: 2003/0055097 (2003-03-01), Zhang et al.
patent: 2003/0134774 (2003-07-01), Steinberg et al.
patent: 2004/0186055 (2004-09-01), Mochly-Rosen
patent: 2005/0164947 (2005-07-01), Mochly-Rosen et al.
patent: 2006/0148700 (2006-07-01), Mochly-Rosen et al.
patent: 2006/0148702 (2006-07-01), Mochly-Rosen et al.
patent: 2007/0066526 (2007-03-01), Mochly-Rosen et al.
patent: WO 2005/082367 (2005-09-01), None
Iemitsu et al., “Cardiac hypertrophy by hypertension and exercise training exhibits different gene expression of enzymes in energy metabolism,” Hypertension Res 26(10):829-837, 2003.
The International Search and Written Opinion for PCT Application PCT/IB2005/000600 Search report dated Jan. 2, 2008, 12 pages(2008).
Inagaki et al., “Pharamcological Inhibition of Epsilon PKC Prevents the Progression of Hypertension-Induced Heart Failure”, Database Biosis [Online],Circulation, 114(18)(Suppl S):442 (Abstract only) (2006).
Chen et al.,PNAS, 96(22):12784-12789 (1999).
Chen et al.,Chemistry&Biology, 140:1-7 (2001).
Dorn et al.,PNAS, 96(22):12798-12803 (1999).
Inagaki et al.,Circulation, 108:2304-2307 (2003).
Kubo et al.,FEBS Letters, 223(1):138-142 (1987).
Inagaki Koichi K.
Mochly-Rosen Daria D.
Carlson Karen Cochrane
Harlocker Susan L.
King & Spalding LLP
Kosson Rosanne
Mohr Judy M.
LandOfFree
Method of preventing progression of hypertension-induced... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of preventing progression of hypertension-induced..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of preventing progression of hypertension-induced... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4235836